The QUEST initiative is launched!

Insights

03 Mar 2021

Quest News
Little Green Pharma is proud to announce that it is sponsoring an Australia-wide medical cannabis study called the QUEST Initiative

Little Green Pharma is proud to announce that it is sponsoring an Australia-wide medical cannabis study. The QUality of life Evaluation STudy (The QUEST Initiative) aims to be one of the world’s largest longitudinal studies and is being facilitated by a leading Australian university. The QUEST study objectives are to investigate the quality of life and health economic impacts on patients with chronic diseases prescribed medicinal cannabis.

The Federal Minster for Health, the Honourable Greg Hunt said “the QUEST Initiative represents a significant Australian contribution to the global need for reliable, objective and clinically-relevant quality of life data for patients accessing medicinal cannabis treatments for a broad range of chronic conditions.

The study is guided by an experienced advisory group and endorsed by a range of national bodies, such as MS research Australia, Chronic Pain Australia, Arthritis Australia, Epilepsy Australia and Australian health care provider, HIF.

The study will run for a period of two years and hopes to recruit at least 2,100 patients by June 2021. As the study grows it has the potential to be extended to international patients.

Little Green Pharma will exclusively supply the medicinal cannabis products to patients enrolled in the study.

To learn more about the QUEST initiative or to find out if you could be eligible visit the QUEST initiative.

You might also be interested in

Fleta Solomon MD green polo

Insights

Big plans for Little Green Pharma

Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.

Apr 2020

Greenchpices

Company news

GreenChoices launches

Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.

Aug 2018

Approved stamp image

Insights

Little Green Pharma (ASX:LGP) receives manufacturing permit

We have been granted a new manufacturing permit from the Office of Drug Control. Read more...

May 2020

View all articles